Skip to main content

Be4OneW

The purpose of the Be4OneW project is to provide access to biopharmaceutical care (monoclonal antibodies, vaccines, etc.) to the greatest number of patients, whether in emerging countries or in our European countries, particularly in the event of a shortage or pandemic. To achieve this goal, the present project proposes a...
Read More

Venair

Venair Group is specialized in the production in ISO7 cleanroom of silicone tubings, braided or not, TPE tubings and the assembly of single-use kits. These standard products are available in stock in all our subsidiaries. A Validation Package is supplied with all our products. Venair Group is specialized in the...
Read More

PQE Belgium

PQE Belgium is a subsidiary of PQE Group, an international consultancy company in the field of pharmaceuticals and medical devices. PQE Group was founded in 1998 in Italy and the Belgian subsidiary was created 22 years later, in 2020. PQE Group is a company specializing in the validation of computerized...
Read More

Theramir

Development of a unique platform of specific exosomes: Proof of concept for the solid tumor treatment For many forms of solid tumors (e.g. brain tumors, osteosarcoma, mammary tumors, melanoma), resection of the tumor and treatment for cancer can lead to damage to the function or appearance of part of the...
Read More

Orgenesis (Belgium) SRL

Orgenesis is a pioneering global biotech company which is unlocking the full potential of personalized therapies and closed processing systems through its Cell & Gene Therapy Biotech Platform, with the ultimate aim of providing life changing treatments at the point of care (POCare) to large numbers of patients at low...
Read More

Revatis

RevaTis proposes a global concept in regenerative veterinary medicine based on the combination of growth factors (PRP kits), scaffolds (new generation of hyaluronic acid) and regenerative stem cells.
Read More

iTeos Therapeutics Inc and iTeos Belgium SA

Teos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of differentiated immuno-oncology therapeutics for patients. The company is headquartered in Cambridge, MA with a research center in Gosselies, Belgium. iTeos leverages its understanding of the tumor microenvironment and immunosuppressive pathways to design novel...
Read More

Cell Matters

Cell Matters unleashes cell therapy productivity by turning cryopreservation into a competitive advantage, offering an integrated set of GMP services, in line with regulatory, quality and GMP requirements of cell therapy industry: • Cryopreservation of leukopaks (leukapheresis) in our EU and in US platforms creating a cross-Atlantic regulatory bridge •...
Read More